Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Fort Worth TX, Houston TX, Bartlesville OK,
Sponsor: SoniVie Inc.
Sex: All
Age: 22 - 70+
Code: NCT06559891
Recruiting
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Fort Worth TX, Dallas TX, Austin TX, Huston TX,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase 3, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
for
Diabetic Retinopathy, Macular Edema
Location: Fort Worth TX, Arlington TX, Southlake TX, Katy TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705607
Phase 3, Recruiting
Active & Responsive
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
for
Age-Related Macular Degeneration,
Location: Fort Worth TX, Tyler TX, Lemont IL, Beachwood OH,
Sponsor: i-Lumen Scientific AUS PTY LTD
Sex: All
Age: 60+
Code: NCT06662162
Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Fort Worth TX, Round Rock TX, San Marcos TX, Schertz TX,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)
for
Substance Use Disorders
Location: Fort Worth TX, Dallas TX, Lexington KY, New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07223398
Recruiting
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Fort Worth TX, Dallas TX, Longview TX, Bellaire TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Fort Worth TX, DeSoto TX, St Louis MO, Sioux Falls SD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase 3, Recruiting
Active & Responsive
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
for
Advanced Non-squamous Non-small-cell Lung Cancer,
Location: Fort Lauderdale FL, Austin TX, Baytown TX, Clermont FL,
Sponsor: Genelux Corporation
Sex: All
Age: 18+
Code: NCT06463665
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Dallas TX, Fort Worth TX, Euless TX, Irving TX,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Fort Worth TX, San Antonio TX, Houston TX,
Sponsor: Antares Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07767474
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Location: Fort Worth TX, San Antonio TX, Houston TX,
Sponsor: Flare Therapeutics Inc.
Sex: Male
Age: 18+
Code: NCT07719361
Phase 1, Recruiting
Active & Responsive
IKS014 in Advanced Solid Tumors That Express HER2
for
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Location: Fort Worth TX, Nashville TN, Newport Beach CA,
Sponsor: Iksuda Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT05872295
Phase 1, Recruiting
Active & Responsive
A 2-part Phase 1/2 Open-label Trial on ODM-212
for
Mesothelioma, Pancreatic Cancer,
Location: Fort Worth TX, Irving TX, Orange CA, Fairfax VA,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT07563738
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Fort Worth TX, Dallas TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),
Location: Fort Worth TX, Los Angeles CA
Sponsor: iLeukon Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07452224
Phase 2, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors